These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1216 related articles for article (PubMed ID: 19713601)

  • 21. Additional value of contrast-enhanced ultrasonography for fusion-guided, percutaneous biopsies of focal liver lesions: prospective feasibility study.
    Kang HJ; Kim JH; Lee SM; Yang HK; Ahn SJ; Han JK
    Abdom Radiol (NY); 2018 Dec; 43(12):3279-3287. PubMed ID: 29671007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma.
    Li K; Su ZZ; Xu EJ; Ju JX; Meng XC; Zheng RQ
    BMC Cancer; 2016 Apr; 16():277. PubMed ID: 27090513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of focal liver lesions: comparison of pulse-inversion harmonic contrast-enhanced sonography with contrast-enhanced CT.
    Li R; Guo Y; Hua X; He Y; Ding J; Guo A; Luo M
    J Clin Ultrasound; 2007; 35(3):109-17. PubMed ID: 17295272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography.
    D'Onofrio M; Rozzanigo U; Masinielli BM; Caffarri S; Zogno A; Malagò R; Procacci C
    J Clin Ultrasound; 2005 May; 33(4):164-72. PubMed ID: 15856516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of integrated color-coded perfusion analysis for contrast-enhanced ultrasound (CEUS) after percutaneous interventions for malignant liver lesions: First results.
    Wiesinger I; Beyer LP; Zausig N; Verloh N; Wiggermann P; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2018; 69(1-2):59-67. PubMed ID: 29758936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients.
    Li K; Su Z; Xu E; Huang Q; Zeng Q; Zheng R
    BMC Cancer; 2017 Jan; 17(1):61. PubMed ID: 28103837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization by biopsy or CEUS of liver lesions guided by image fusion between ultrasonography and CT, PET/CT or MRI.
    Ewertsen C; Henriksen BM; Torp-Pedersen S; Bachmann Nielsen M
    Ultraschall Med; 2011 Apr; 32(2):191-7. PubMed ID: 21225564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring during hepatic radiofrequency ablation (RFA): comparison of real-time ultrasound elastography (RTE) and contrast-enhanced ultrasound (CEUS): first clinical results of 25 patients.
    Wiggermann P; Brünn K; Rennert J; Loss M; Wobser H; Schreyer AG; Stroszczynski C; Jung EM
    Ultraschall Med; 2013 Dec; 34(6):590-4. PubMed ID: 24132649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified contrast-enhanced ultrasonography with the new high-resolution examination technique of high frame rate contrast-enhanced ultrasound (HiFR-CEUS) for characterization of liver lesions: First results.
    Jung EM; Moran VO; Engel M; Krüger-Genge A; Stroszczynski C; Jung F
    Clin Hemorheol Microcirc; 2023; 83(1):31-46. PubMed ID: 35466932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
    Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
    Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomography.
    Paul SB; Dhamija E; Gamanagatti SR; Sreenivas V; Yadav DP; Jain S; Shalimar ; Acharya SK
    Diagn Interv Imaging; 2017 Mar; 98(3):253-260. PubMed ID: 27692674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-dimensional contrast-enhanced ultrasound of the liver: experience of 92 cases.
    Xu HX; Lu MD; Xie XH; Xie XY; Xu ZF; Chen LD; Liu GJ; Liang JY; Lin MX; Wang Z; Huang B
    Ultrasonics; 2009 Mar; 49(3):377-85. PubMed ID: 19041996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraprocedural contrast-enhanced ultrasound-CT/MR fusion imaging assessment in HCC thermal ablation to reduce local tumor progression: compared with routine contrast-enhanced ultrasound.
    Ju JX; Zeng QJ; Xu EJ; He XQ; Tan L; Huang QN; Li K; Zheng RQ
    Int J Hyperthermia; 2019; 36(1):785-793. PubMed ID: 31431086
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors.
    Xu E; Long Y; Li K; Zeng Q; Tan L; Luo L; Huang Q; Zheng R
    Int J Hyperthermia; 2019 Jan; 35(1):159-167. PubMed ID: 30300032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice.
    Sporea I; Badea R; Popescu A; Spârchez Z; Sirli RL; Dănilă M; Săndulescu L; Bota S; Calescu DP; Nedelcu D; Brisc C; Ciobâca L; Gheorghe L; Socaciu M; Martie A; Ioaniţescu S; Tamas A; Streba CT; Iordache M; Simionov I; Jinga M; Anghel A; Cijevschi Prelipcean C; Mihai C; Stanciu SM; Stoicescu D; Dumitru E; Pietrareanu C; Bartos D; Manzat Saplacan R; Pârvulescu I; Vădan R; Smira G; Tuţă L; Săftoiu A
    Ultraschall Med; 2014 Jun; 35(3):259-66. PubMed ID: 24563420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study.
    Cho YZ; Park SY; Choi EH; Baik SK; Kwon SO; Kim YJ; Cha SH; Kim MY
    Clin Mol Hepatol; 2015 Jun; 21(2):165-74. PubMed ID: 26157754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the diagnostic accuracy of CEUS in children with benign and malignant liver lesions and portal vein anomalies.
    Pschierer K; Grothues D; Rennert J; da Silva NP; Schreyer AG; Melter M; Stroszczysnski C; Jung EM
    Clin Hemorheol Microcirc; 2015; 61(2):333-45. PubMed ID: 26444615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablation.
    Wang Y; Jing X; Ding J
    Clin Imaging; 2016; 40(3):402-6. PubMed ID: 27133676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.
    Murakami T; Imai Y; Okada M; Hyodo T; Lee WJ; Kim MJ; Kim T; Choi BI
    Oncology; 2011; 81 Suppl 1():86-99. PubMed ID: 22212941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.